ABSI News and Press, Absci Corporation From 12/26/23

2023-12-26 13:19:21 ET More on AbCellera Biologics, Absci, etc. Exscientia Looks Promising In AI-Driven Drug Development AbCellera: Difficult 2023 Suggests Business Model Should Pivot In 2024 Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platf...

Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments With this partnership, Absci achieves 2023 outlook of ten new Active Programs signed for the year VANCOUVER, Wash., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ab...

2023-12-10 13:04:00 ET More on AbCellera Biologics, Absci, etc. AbCellera: Difficult 2023 Suggests Business Model Should Pivot In 2024 Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform Certara, Inc. 2023 Q3 - Results - Earnings Call Prese...

2023-12-04 10:02:05 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: Ocular Therapeutix, EyePoint Pharmaceuticals among healthcare movers

2023-12-04 07:49:22 ET More on Absci, AstraZeneca, etc. AstraZeneca Pays Hefty Price For Chinese Weight-Loss Drug AstraZeneca PLC 2023 Q3 - Results - Earnings Call Presentation AstraZeneca PLC (AZN) Q3 2023 Earnings Call Transcript EU regulators seeking more ...

VANCOUVER, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a leader in generative AI antibody discovery, today announced a collaboration with AstraZeneca, a global biopharmaceutical company, to deliver an AI-designed antibody against an oncology target. This collaborati...

2023-11-21 09:27:03 ET More on Nvidia, Roche, etc. Nvidia Q3 Earnings Preview: Know The Risks And The Reward Nvidia: Smooth Sailing Nvidia Fiscal Q3 Earnings Preview: Big Wave Surfing 4 stocks to watch on Tuesday: Nvidia, Abercrombie & Fitch and more ...

2023-11-15 08:24:52 ET Graphite Bio GRPH -15% following reverse merger with LENZ Therapeutics in all-stock deal . Global E Online GLBE -15% on Q3 earnings release . Tivic Health Systems TIVC -15% on Q3 earnings release . reAlpha Tech ( AIRE ) -14%...

VANCOUVER, Wash. and NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Piper Sandler 35 th Annual Healthcare Conference in New York, NY. Absci management ...

2023-11-14 17:26:35 ET More on Absci Absci, Almirall partner on dermatologic drug development Seeking Alpha’s Quant Rating on Absci Historical earnings data for Absci Financial information for Absci For further details see: Absci GAAP EPS o...